Markedly increased serum and urinary fructose concentrations in diabetic patients with ketoacidosis or ketosis

被引:16
作者
Kawasaki, Takahiro [1 ,2 ]
Igarashi, Kanji [1 ]
Ogata, Nobuyuki [1 ]
Oka, Yoko [1 ]
Ichiyanagi, Kaoru [1 ]
Yamanouchi, Toshikazu [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 1738605, Japan
[2] Kawakita Gen Hosp, Dept Internal Med, Kawakita, Japan
关键词
Fructose; Diabetic ketoacidosis; Type; 1; diabetes; Atypical diabetes; Gas chromatography-mass fragmentography; MELLITUS;
D O I
10.1007/s00592-010-0179-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate fructose concentrations in diabetic patients with ketoacidosis or ketosis, serum fructose concentrations and daily urinary fructose excretion were measured in 23 patients with ketoacidosis (n = 16) and ketosis (n = 7) on the first day of admission. Seventeen patients were diagnosed with type 1, one patient with mitochondrial, and 4 patients with atypical diabetes. In 16 of the 23 patients, serum and urinary fructose could be assessed after starting treatments. Mean serum fructose concentration was 71.6 +/- A 108.1 mu mol/l, and mean daily urinary fructose excretion was 352.1 +/- A 473.7 mu mol/day. Serum fructose levels in patients with atypical diabetes were much higher (205.0 +/- A 213.3 mu mol/l) than those in patients with type 1 diabetes (45.1 +/- A 44.5 mu mol/l), while urinary fructose levels in atypical diabetes (249.7 +/- A 92.4 mu mol/day) tended to be lower than those in type 1 diabetes (382.6 +/- A 533.2 mu mol/day). Serum fructose concentrations decreased significantly (P < 0.05) from 88.1 +/- A 126.3 to 18.0 +/- A 11.0 mu mol/l, and daily urinary fructose excretion also decreased significantly (P < 0.05) from 459.8 +/- A 530.9 to 75.1 +/- A 62.0 mu mol/day in accordance with glycemic normalization after treatment. Marked and reversible increases in serum and urinary fructose concentrations were observed in diabetics with ketoacidosis and ketosis.
引用
收藏
页码:119 / 123
页数:5
相关论文
共 13 条
[1]  
[Anonymous], 2004, Diabetes Care, V27, pS94
[2]   New profiles of diabetic ketoacidosis -: Type 1 vs type 2 diabetes and the effect of ethnicity [J].
Balasubramanyam, A ;
Zern, JW ;
Hyman, DJ ;
Pavlik, V .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (19) :2317-2322
[3]   GAD ANTIBODY NEGATIVE NIDDM IN ADULT BLACK SUBJECTS WITH DIABETIC-KETOACIDOSIS AND INCREASED FREQUENCY OF HUMAN-LEUKOCYTE ANTIGEN DR3 AND DR4 - FLATBUSH DIABETES [J].
BANERJI, MA ;
CHAIKEN, RL ;
HUEY, H ;
TUOMI, T ;
NORIN, AJ ;
MACKAY, IR ;
ROWLEY, MJ ;
ZIMMET, PZ ;
LEBOVITZ, HE .
DIABETES, 1994, 43 (06) :741-745
[4]   Fructose, weight gain, and the insulin resistance syndrome [J].
Elliott, SS ;
Keim, NL ;
Stern, JS ;
Teff, K ;
Havel, PJ .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (05) :911-922
[5]   Postprandial plasma fructose level is associated with retinopathy in patients with type 2 diabetes [J].
Kawasaki, T ;
Ogata, N ;
Akanuma, H ;
Sakai, T ;
Watanabe, H ;
Ichiyanagi, K ;
Yamanouchi, T .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (05) :583-588
[6]   Increased fructose concentrations in blood and urine in patients with diabetes [J].
Kawasaki, T ;
Akanuma, H ;
Yamanouchi, TY .
DIABETES CARE, 2002, 25 (02) :353-357
[7]   ROLE OF FRUCTOSE IN GLYCATION AND CROSS-LINKING OF PROTEINS [J].
MCPHERSON, JD ;
SHILTON, BH ;
WALTON, DJ .
BIOCHEMISTRY, 1988, 27 (06) :1901-1907
[8]   Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome [J].
Nakagawa, T ;
Tuttle, KR ;
Short, RA ;
Johnson, RJ .
NATURE CLINICAL PRACTICE NEPHROLOGY, 2005, 1 (02) :80-86
[9]   Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus - Clinical and biochemical differences [J].
Newton, CA ;
Raskin, P .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (17) :1925-1931
[10]   DIABETIC-KETOACIDOSIS IN OBESE AFRICAN-AMERICANS [J].
UMPIERREZ, GE ;
CASALS, MC ;
GEBHART, SSP ;
MIXON, PS ;
CLARK, WS ;
PHILLIPS, LS .
DIABETES, 1995, 44 (07) :790-795